{"page_content": "ESG R eport 2021ESG PROGRAM  OBJECTIVES\nOur vision to make the world a better place is foundational to Agios. We are driven to improve the lives of those fighting life-threatening \nand life-altering genetically defined diseases, including those that have often been overlooked or neglected. We have pioneered two novel \ntherapeutic approaches \u2013 IDH inhibition and PKR activation \u2013 and continue to focus on creating an environment in which scientific innovation \non behalf of patients can thrive. Our ESG program is centered around our commitments to:\nPATIENTS08\nOUR COMMUNITIES  \n& WORLD23EMPLOYEES15\nETHICS & VALUES27PAGE\nPAGE\nPAGE\nPAGE\n4", "metadata": {"source": "NASDAQ_AGIO_2020.pdf", "page": 3, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}